|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.875 SEK | +0.54% |
|
-14.77% | -1.32% |
| 20/07 | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| 16/07 | Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 453M 398M 370M 340M 638M 43.84B 649M 4.42B 1.73B 21.38B 1.7B 1.66B 74.19B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 421M 370M 344M 316M 593M 40.73B 603M 4.11B 1.6B 19.87B 1.58B 1.54B 68.92B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.54% | ||
| 1 week | -14.77% | ||
| Current month | -21.88% | ||
| 1 month | -19.87% | ||
| 3 months | -33.04% | ||
| 6 months | -5.06% | ||
| Current year | -1.32% |
| 1 week | 1.61 |  | 2.25 |
| 1 month | 1.61 | | 2.64 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 13.4 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Ulf Thomas Blom
COO | Chief Operating Officer | 61 | 01/01/2011 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/7/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 1/4/26 | Sell | Responsable ventes & marketing | 40,000 | 0.0165% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.54% | -14.77% | -30.30% | -32.92% | 46.33M | |
| +1.97% | +1.43% | +48.44% | +156.66% | 1,057B | |
| +1.42% | +3.72% | +53.32% | +52.34% | 624B | |
| +1.43% | +0.99% | +34.83% | +78.74% | 454B | |
| +1.37% | +5.72% | +33.27% | +29.18% | 341B | |
| -0.60% | +1.31% | +35.40% | +39.47% | 297B | |
| -0.20% | +0.46% | +16.01% | +17.37% | 262B | |
| +0.05% | -2.85% | -28.31% | -41.73% | 215B | |
| +1.49% | -0.02% | +20.14% | +58.21% | 201B | |
| +0.40% | -3.99% | +15.23% | +62.28% | 162B | |
| Average | +0.03% | -0.75% | +19.80% | +41.96% | 361.4B | |
| Weighted average by Cap. | -0.03% | +1.57% | +35.08% | +75.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 40.08M 37.24M 34.25M 64.23M 4.41B 65.38M 445M 174M 2.15B 171M 167M 7.47B | 53.9M 47.41M 44.04M 40.51M 75.96M 5.22B 77.32M 527M 205M 2.55B 202M 198M 8.83B |
| Net income | -53.18M -46.77M -43.45M -39.96M -74.94M -5.15B -76.29M -520M -203M -2.51B -200M -195M -8.71B | -51.89M -45.64M -42.4M -38.99M -73.13M -5.03B -74.44M -507M -198M -2.45B -195M -191M -8.5B |
| Net Debt | -73.01M -64.21M -59.65M -54.86M -103M -7.07B -105M -713M -278M -3.45B -274M -268M -11.96B | -32.11M -28.24M -26.24M -24.13M -45.25M -3.11B -46.06M -314M -122M -1.52B -121M -118M -5.26B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | SEK 1.875 | +0.54% | 53,422 |
| 23/07/26 | SEK 1.865 | +0.27% | 162,793 |
| 22/07/26 | SEK 1.860 | -9.27% | 392,131 |
| 21/07/26 | SEK 2.050 | -6.39% | 124,264 |
| 20/07/26 | SEK 2.190 | -0.45% | 54,536 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
